隐秘过渡期间的非线性进展确定了癌症的致死率
Joshua D Ginzel1,2, Henry Chapman1, Joelle E Sills1
1Department of Surgery, Duke University, Durham, NC 27710, USA.
Disease models & mechanisms
|March 19, 2025
概括
癌症的进展可能不是线性的. 新的研究表明,早期癌症成为致命的关键"隐秘"过渡,挑战目前的乳腺癌查模型.
科学领域:
- 在瘤学瘤学.
- 癌症生物学 癌症生物学
- 遗传学 遗传学是一种遗传学.
背景情况:
- 目前的癌症查模型假定瘤的生长和进展是线性的.
- 历史数据表明,恶性进展与瘤生长无关,这可能解释了早期检测增加而不减少转移.
研究的目的:
- 通过在小鼠模型中使用血统追踪来研究癌症的非线性进展.
- 挑战瘤发展的线性模型,这是当前癌症查范式的基础.
主要方法:
- 利用癌症彩虹小鼠模型来追踪数百万个转变细胞和数千个瘤的血统.
- 采用一个动态模型来估计从野外细胞到屏幕检测和症状瘤的过渡率.
- 进行了移植检测,以验证发现.
主要成果:
- 确定了一个关键的"隐秘"过渡,转变的细胞成为真正的瘤.
- 证明,与过渡到症状性瘤相比,野外细胞成为屏幕可检测的瘤的可能性明显低.
- 揭示了神秘过渡期间的非线性进展导致查期间检测到的致命癌症.
结论:
- 癌症的进展偏离了线性模型,特别是在隐秘过渡阶段.
- 隐秘过渡率是瘤生长和恶性瘤的关键决定因素.
- 这些发现挑战了当前癌症查策略的基本假设,特别是在HER2阳性乳腺癌中.
相关概念视频
Tumor Progression
6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K
Cancers Originate from Somatic Mutations in a Single Cell
11.4K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
11.4K
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Cancer Survival Analysis
315
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
315
Cancer-Critical Genes I: Proto-oncogenes
8.6K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.6K
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K


